Goldman Sachs maintains Shanghai Bairun at Neutral, cuts 26-27E forecasts and sets an Rmb18.6 target price
AI summary card
Goldman Sachs maintains Shanghai Bairun at Neutral, cuts 26-27E forecasts and sets an Rmb18.6 target price
The report updates its model following the 2Q26 profit alert: 1H26 net profit midpoint growth was 23% yoy, but Goldman Sachs lowered its 2026E-2027E revenue and net profit forecasts due to 2025 results falling below expectations and lower whisky sales assumptions.
- Shanghai Bairun announced its 2Q26/1H26 profit alert, with 1H26 net profit midpoint growth of 23% yoy and implied 2Q26 net profit growth of 26% yoy, approximately 5%/9% above Goldman Sachs' forecasts, respectively.
- Goldman Sachs lowered its 2026E-2027E sales forecasts by 7%-10%, mainly due to 2025 results falling below expectations and the 2026E whisky sales forecast being reduced from Rmb550mn to Rmb200mn.
- 2026E/2027E net profit forecasts were lowered by 6%/10%, respectively, due to lower revenue assumptions and a slightly higher selling expense ratio.
- Goldman Sachs expects 2026E-2028E revenue growth of 7%-10% and net profit growth of 12%-21%; it lowered the 12-month target price from Rmb20 to Rmb18.6 and maintained Neutral.
Report interpretation
Overview
This is an event commentary/data update report by Goldman Sachs on Shanghai Bairun (002568.SZ). The key trigger was the company's disclosure of its 2Q26/1H26 profit alert: 1H26 net profit midpoint growth was 23% yoy, implying 2Q26 net profit growth of 26% yoy, above Goldman Sachs' original forecast. Despite the short-term profit alert exceeding expectations, Goldman Sachs lowered its 2026E-2027E revenue and net profit forecasts and reduced the 12-month target price to Rmb18.6, maintaining a Neutral rating, due to 2025 results falling below expectations, lower whisky business sales assumptions, and a slightly higher selling expense ratio.
Core views
Goldman Sachs believes the company's profit alert demonstrates resilient earnings growth, while RTD cocktail sales growth provides some support for revenue. However, progress in the whisky business was below previous assumptions, and the 2026E sales forecast was sharply reduced to Rmb200mn. Combined with revenue base and expense ratio pressure, this led to 2026E/2027E net profit forecast cuts of 6%/10%, respectively. Under the new forecasts, Goldman Sachs expects 2026E-2028E revenue growth of 7%-10% and net profit growth of 12%-21%. The target price implies approximately 11% upside, which is insufficient to support a more positive rating; therefore, Goldman Sachs maintained Neutral.
Analysis framework
The report uses a post-profit-alert model update framework, comparing the company's disclosed 1H26 and 2Q26 net profit growth with Goldman Sachs' original forecasts and adjusting its 2026E-2028E revenue, net profit, whisky sales, and expense ratio assumptions accordingly. For valuation, the target price is based on a 2027E P/E multiple and discounted back to mid-2027E.
Methodology notes
23x 2027E P/E discounted valuation
Goldman Sachs' 12-month target price of Rmb18.6 is based on 23x 2027E P/E, discounted back to mid-2027E using a 9.9% cost of equity, with other assumptions unchanged.
Growth, financial returns, valuation multiples, and composite factors
Goldman Sachs' Factor Profile compares stocks on a relative basis using growth, financial returns, valuation multiples, and composite percentiles, supplementing the investment background and peer comparison.
Probability ranking of acquisition targets
Goldman Sachs uses M&A Rank across its global coverage to assess a company's potential probability of becoming an acquisition target. The report discloses the framework's general definition but does not provide Shanghai Bairun's specific M&A ranking.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Shanghai Bairun (002568.SZ)Core covered stock
- Strengths
- 1H26 and 2Q26 net profit growth exceeded Goldman Sachs' expectations; RTD cocktail sales growth supported revenue; updated forecasts still project double-digit net profit growth in 2026E-2028E.
- Weaknesses
- 2025 results fell below expectations; whisky sales assumptions were sharply reduced; a slightly higher selling expense ratio led to lower earnings forecasts.
- Comparison
- The rating is relative to Goldman Sachs' coverage universe of Chinese food, beverage, and related consumer goods companies, including baijiu, beer, dairy, beverage, and condiment companies.
- Risks
- Demand growth faster or slower than expected, changes in competitive intensity, selling expenses higher or lower than expected, and raw material risks.
Key data
- 1H26 net profit growth+23% yoyBased on the company's profit alert midpoint.
- Implied 2Q26 net profit growth+26% yoyApproximately 9% above Goldman Sachs' forecast; 1H26 net profit was approximately 5% above Goldman Sachs' forecast.
- 2026E-2027E sales forecast adjustmentDown 7%-10%Mainly due to 2025 results falling below expectations and lower whisky sales assumptions, partially offset by RTD cocktail growth.
- 2026E whisky sales forecastRmb200mnThe previous forecast was Rmb550mn; the 2Q run rate was approximately Rmb50mn in sales.
- 2026E/2027E net profit forecast adjustmentDown 6%/10%Due to lower sales forecasts and a slightly higher selling expense ratio.
- 2026E-2028E revenue growth forecast7%-10%Goldman Sachs' updated forecast range.
- 2026E-2028E net profit growth forecast12%-21%Goldman Sachs' updated forecast range.
- 12-month target priceRmb18.6The previous target price was Rmb20, implying approximately 11% upside.
- Valuation assumptions23x 2027E P/E; COE 9.9%Discounted back to mid-2027E.
Impact & implications
The report's investment implication is neutral: the profit alert was better than Goldman Sachs' short-term expectations, indicating continued earnings momentum. However, the significant reduction in whisky sales assumptions weakens medium-term revenue elasticity, while expense ratio pressure also lowers earnings forecasts. Although the target price was reduced, it still implies approximately 11% upside, supporting a Neutral rating rather than an upgrade.
Risks
- Slower-than-expected demand growth could constrain revenue and profit recovery.
- Intensifying competition could affect RTD cocktail or related business growth and margins.
- A higher-than-expected selling expense ratio could continue to weigh on net profit.
- Raw material price volatility could affect gross margins.
- Lower-than-expected whisky business sales progress could weaken medium-term growth elasticity.
What to watch
- Whether subsequent quarterly RTD cocktail sales growth can offset the slowdown in the whisky business.
- Whether 2026E whisky sales can reach the new forecast of Rmb200mn.
- Changes in the selling expense ratio and their impact on net profit margins.
- Whether 2H26 revenue and net profit growth can sustain the strong performance indicated by the profit alert.
- Whether Goldman Sachs further adjusts its target price, rating, or 2027E valuation multiple assumptions.